United States · FDA National Drug Code directory
TEVIMBRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72579-125_d46bfb2e-44c4-4a86-8a8f-b38fb01ac4b6
- Product NDC
- 72579-125
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- tislelizumab-jsgr
- Labeler
- BeOne Medicines USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260713
- Source listing expiry
- 20271231
Source-listed ingredients
- TISLELIZUMAB — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (72579-125-00) / 15 mL in 1 VIAL, GLASS · 72579-125-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →